GIM
MRTX

Granahan Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Granahan Investment Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-145,175
Closed -$6.32M – 200
2023
Q3 		$6.32M Sell
145,175
-112
-0.1% -$4.88K 0.23% 114
2023
Q2 		$5.25M Buy
145,287
+16,197
+13% +$585K 0.16% 129
2023
Q1 		$4.8M Buy
129,090
+37,190
+40% +$1.38M 0.15% 130
2022
Q4 		$4.16M Buy
+91,900
New +$4.16M 0.13% 140